Although the landmark randomized trials treated up to 64 Gy, there is data out of Italy suggesting that higher doses yield better biochemical control (https://www.ncbi.nlm.nih.gov/pubmed/19619960?dopt=Abstract). Can dose escalation be done safely in post-prostatectomy patients?